These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 9816201)
1. Tissue and tumor distribution of C-penclomedine in rats. O'Reilly S; Hartman NR; Grossman SA; Strong JM; Struck RF; Eller S; Lesser GJ; Donehower RC; Rowinsky EK Clin Cancer Res; 1996 Mar; 2(3):541-8. PubMed ID: 9816201 [TBL] [Abstract][Full Text] [Related]
2. Murine and human in vivo penclomedine metabolism. Hartman NR; O'Reilly S; Rowinsky EK; Collins JM; Strong JM Clin Cancer Res; 1996 Jun; 2(6):953-62. PubMed ID: 9816256 [TBL] [Abstract][Full Text] [Related]
3. Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brain. Harrison SD; Plowman J; Dykes DJ; Waud WR; Griswold DP Cancer Res; 1991 Apr; 51(8):1979-83. PubMed ID: 2009516 [TBL] [Abstract][Full Text] [Related]
4. The in vitro metabolism of penclomedine in mouse, rat, and human systems. Hartman NR; Leo KU; Brewer TG; Strong JM Drug Metab Dispos; 1998 Jun; 26(6):513-9. PubMed ID: 9616185 [TBL] [Abstract][Full Text] [Related]
5. Preclinical antitumor activity of an alpha-picoline derivative, penclomedine (NSC 338720), on human and murine tumors. Plowman J; Harrison SD; Dykes DJ; Paull KD; Narayanan VL; Tobol HK; Martin J; Griswold DP Cancer Res; 1989 Apr; 49(8):1909-15. PubMed ID: 2702634 [TBL] [Abstract][Full Text] [Related]
6. Murine pharmacokinetics and metabolism of penclomedine [3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine, NSC 338720]. Reid JM; Mathiesen DA; Benson LM; Kuffel MJ; Ames MM Cancer Res; 1992 May; 52(10):2830-4. PubMed ID: 1581896 [TBL] [Abstract][Full Text] [Related]
7. Phase I clinical and pharmacokinetic study of oral penclomedine (NSC 338720) in adults with advanced solid malignancy. Liu G; Berlin J; Tutsch KD; Van Ummersen L; Dresen A; Marnocha R; Arzomanian R; Alberti D; Feierabend C; Binger K; Wilding G Clin Cancer Res; 2002 Mar; 8(3):706-11. PubMed ID: 11895899 [TBL] [Abstract][Full Text] [Related]
8. Distribution of (7alpha)-21-[4-[(diethylamino) methyl]-2-methoxyphenoxy]-7-methyl-19-norpregna-1,3,5(10)-trien-3-ol-20-[14C]2-hydroxy-1,2,3-propanetricarboxylate ([14C]TAS-108) and its metabolites after single oral administration to rats bearing 7,12-dimethylbenz(alpha)anthracene-induced mammary tumor. Yamaya H; Saeki M; Yoshida K; Shibata J; Yano S; Sato Y; Takao A; Shindo T; Buzdar AU; Nagayama S Drug Metab Dispos; 2006 Feb; 34(2):331-8. PubMed ID: 16299166 [TBL] [Abstract][Full Text] [Related]
10. Tissue distribution and elimination of N-methyl-N-2,4,6-tetranitroaniline (tetryl) in rats. Myers SR; Spinnato JA Arch Toxicol; 2007 Dec; 81(12):841-8. PubMed ID: 17680234 [TBL] [Abstract][Full Text] [Related]
11. Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues. Osman S; Rowlinson-Busza G; Luthra SK; Aboagye EO; Brown GD; Brady F; Myers R; Gamage SA; Denny WA; Baguley BC; Price PM Cancer Res; 2001 Apr; 61(7):2935-44. PubMed ID: 11306471 [TBL] [Abstract][Full Text] [Related]
12. Bioavailability of penclomedine and systemic exposure to 4-O-demethylpenclomedine in patients receiving oral and intravenous penclomedine. O'Reilly S; Hartman NR; Bowling KM; Rowinsky EK; Donehower RC; Collins J; Strong JM Cancer Chemother Pharmacol; 2001 Sep; 48(3):223-8. PubMed ID: 11592344 [TBL] [Abstract][Full Text] [Related]
13. Tissue distribution and depletion kinetics of bortezomib and bortezomib-related radioactivity in male rats after single and repeated intravenous injection of 14 C-bortezomib. Hemeryck A; Geerts R; Monbaliu J; Hassler S; Verhaeghe T; Diels L; Verluyten W; van Beijsterveldt L; Mamidi RN; Janssen C; De Coster R Cancer Chemother Pharmacol; 2007 Nov; 60(6):777-87. PubMed ID: 17285316 [TBL] [Abstract][Full Text] [Related]
14. Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors. Blasberg R; Horowitz M; Strong J; Molnar P; Patlak C; Owens E; Fenstermacher J Cancer Res; 1985 Apr; 45(4):1692-701. PubMed ID: 3978636 [TBL] [Abstract][Full Text] [Related]
15. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo. O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895 [TBL] [Abstract][Full Text] [Related]
17. Regional [14C]misonidazole distribution in experimental RT-9 brain tumors. Horowitz M; Blasberg R; Molnar P; Strong J; Kornblith P; Pleasants R; Fenstermacher J Cancer Res; 1983 Aug; 43(8):3800-7. PubMed ID: 6861144 [TBL] [Abstract][Full Text] [Related]
18. Tissue distribution of 14C-diazepam and its metabolites in rats. Igari Y; Sugiyama Y; Sawada Y; Iga T; Hanano M Drug Metab Dispos; 1982; 10(6):676-9. PubMed ID: 6130922 [TBL] [Abstract][Full Text] [Related]
19. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
20. Penclomedine-induced DNA fragmentation and p53 accumulation correlate with reproductive cell death in colorectal carcinoma cells with altered p53 status. Rakovitch E; Mellado W; Hall EJ; Sawant SG; Geard CR; Newman RA; Pandita TK Oncol Rep; 1999; 6(1):161-5. PubMed ID: 9864421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]